According to the Global Burden of Diseases and Institute for Health Metrics and Evaluation, the number of deaths caused by vaccine-preventable diseases such as tuberculosis decreased from 1.7 million in 2000 to 1.2 million in 2016.
Pune, India - June 28, 2019 /MarketersMedia/ —
Meticulous Research® in its latest publication on Vaccines Market states that the global vaccines market is expected to reach $57.50 billion by 2025 from $31.43 billion in 2017, growing at a CAGR of 7.9% from 2018-2025.
Over last decade, the field of vaccine development has received huge support from pharmaceutical industry as well as governments. This is mainly attributed to successful vaccination programs which helped in eradication of infectious diseases such as chicken pox and Polio in some parts of the world which in turn saved billions of dollars on healthcare expenditure. Vaccines are one of the most powerful and cost-effective health interventions available. Yet many preventable diseases still cost millions of lives and billions of dollars every year. Vaccine manufacturers are key stakeholders in addressing this concern. GlaxoSmithKline plc, Johnson & Johnson, Merck & Co., Inc., Pfizer Inc., Sanofi, Serum Institute of India Pvt. Ltd., Daiichi Sankyo Co., Ltd., and Takeda Pharmaceutical Co., Ltd. are some of the major providers of vaccines in the market. These companies continuously engage in developing new vaccines for new indications. The strength of the product pipeline of these companies is indicative of the growth and demand of vaccines in the global market.
Request Sample Report: https://www.meticulousresearch.com/request-sample-report/cp_id=4813
Some companies have portfolios of highly profitable vaccines and small vaccine pipelines. In such cases the companies’ access considerations mainly relate to pricing, registration and supply. Other companies have small portfolios, but larger pipelines supported by proportionally high investments in vaccine R&D. For these companies, the focus is on ensuring vaccine development to meet global health needs and on putting measures in place to ensure that successful vaccines will be accessible.
At present, the global pipeline of vaccines development is strong with many companies developing several vaccines for multiple indications. Many of these are expected to enter the market over the next 3 to 5 years, creating additional revenue streams for respective companies and driving the growth of the global vaccines market during the forecast period.
On the other hand, rising health awareness, increasing healthcare expenditure, rising per capita income, and growing healthcare infrastructure has led to rise in the adoption of vaccination for preventing the incidence of infectious diseases, globally.
According to the Global Burden of Diseases and Institute for Health Metrics and Evaluation, the number of deaths caused by vaccine-preventable diseases such as tuberculosis decreased from 1.7 million in 2000 to 1.2 million in 2016. Moreover, although the incidence of Hepatitis is increasing year on year, the number of deaths caused by the hepatitis B has decreased from 33.8 thousand in 2005 to 21.4 thousand in 2016.
Thus, strong vaccines pipeline and growing adoption of vaccination is expected to propel the growth of the global vaccines market.
Browse in-depth Report on https://www.meticulousresearch.com/product/vaccines-market/
Key Topics Covered in This Report:
1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Share Analysis
5. Market Insights
6. Vaccines Market, by Indication
6.1. Overview
6.2. Pneumococcal Disease
6.3. Influenza
6.4. DTP
6.5. Human Papilloma Virus (HPV)
6.6. Meningococcal Disease
6.7. Poliomyelitis (Polio)
6.8. MMR
6.9. Rotavirus
6.10. Hepatitis
6.11. Others
7. Vaccines Market, by Route of Administration
7.1. Overview
7.2. Intramuscular (IM)
7.3. Subcutaneous (SC)
7.4. Oral
7.5. Other (Routes of Administration)
8. Vaccines Market, by Type/Antigen
8.1. Overview
8.2. Subunit & Conjugate Vaccines
8.3. Inactivated Vaccines
8.4. Live Attenuated Vaccines
8.5. Toxoid Vaccines
9. Vaccines Market, by Valence
9.1. Overview
9.2. Multivalent Vaccines
9.3. Monovalent Vaccines
10. Geographic Analysis
11. Competitive Landscape
12. Company Profiles (Includes Business Overview, Financial Overview, Product Portfolio, and Strategic Developments)
12.1. Sanofi Pasteur
12.2. Merck & Co., Inc.
12.3. GlaxoSmithKline Plc
12.4. Pfizer, Inc.
12.5. Johnson & Johnson
12.6. Daiichi Sankyo
12.7. Takeda Pharmaceutical Co. Ltd.
12.8. CSL Limited
12.9. Emergent BioSolutions Inc.
12.10. AstraZeneca
13. Appendix
Download Details TOC of Report @ https://www.meticulousresearch.com/download-sample-report/cp_id=4813
Contact Info:
Name: Khushal
Email: Send Email
Organization: Meticulous Market Research Pvt. Ltd.
Address: Pune, India
Phone: +91-744-7780008
Website: https://www.meticulousresearch.com/product/vaccines-market/
Source: MarketersMedia
Release ID: 88891014
